Lihua Hou
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 10
- Viral Infections and Outbreaks Research 9
- Viral gastroenteritis research and epidemiology 5
- Molecular Medicine top 10%
- Health top 10%
- Modeling and Simulation top 10%
- Pharmaceutical Science top 10%
-
- Virus-based gene therapy research 15
-
- Immunotherapy and Immune Responses 5
-
- RNA Interference and Gene Delivery 4
-
- Hepatitis B Virus Studies 4
-
- CAR-T cell therapy research 3
- Co-authors
- Shipo WuWei ChenXiaohong SongBusen WangZhe ZhangQiang GuoGuodong YangShimin Yin
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Lihua Hou
35 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 519
- Molecular Medicine 54
- Health 85
- Modeling and Simulation 36
- Pharmaceutical Science 44
Countries citing papers authored by Lihua Hou
This map shows the geographic impact of Lihua Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihua Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihua Hou more than expected).
Fields of papers citing papers by Lihua Hou
This network shows the impact of papers produced by Lihua Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihua Hou. The network helps show where Lihua Hou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lihua Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 12 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 30 | |
| 9 | 2023 | 22 | |
| 10 | 2023 | 55 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 15 | |
| 14 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialbreakdown → | 2021 | 192 |
| 15 | 2018 | 98 | |
| 16 | 2017 | 6 | |
| 17 | 2016 | 77 | |
| 18 | 2016 | 30 | |
| 19 | 2013 | 5 | |
| 20 | 2012 | 47 |
About Lihua Hou
Lihua Hou is a scholar working on Infectious Diseases, Genetics and Animal Science and Zoology, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Viral Infections and Outbreaks Research (9 papers), Viral gastroenteritis research and epidemiology (5 papers), Immunotherapy and Immune Responses (5 papers), RNA Interference and Gene Delivery (4 papers), Hepatitis B Virus Studies (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Infectious Diseases (519 citations), Molecular Medicine (54 citations) and Health (85 citations). Lihua Hou has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Shipo Wu, Wei Chen, Xiaohong Song, Busen Wang, Zhe Zhang, Qiang Guo, Guodong Yang, Shimin Yin, Yongjun Wang and Jialei Yang. Their work appears in journals such as The Lancet, Advanced Materials and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.